Studies performed in Western Europe, North America, and East Asia have shown high levels of anti-gp210-specific antibodies in PBC patients [17,18,19,53,54], which has also been confirmed in the Polish population. This evidence concerns the gene NUP210 and primary biliary cholangitis.